Skip to main content

Table 2 Characteristics of participants at baseline

From: Effectiveness of workshops to teach a home-based exercise program (BEST at Home) for preventing falls in community-dwelling people aged 65 years and over: a pragmatic randomised controlled trial

Characteristics Intervention Control All
Age (years), mean (SD) 72.9 (6.2) n = 307 73.2 (5.8) n = 310 73.1 (6.0) n = 617
Female: n (%) 196 (63.8) n = 307 197 (63.6) n = 310 393 (63.7) n = 617
Lives alone: n (%) 89 (29.0) n = 307 97 (31.3) n = 310 186 (30.2) n = 617
Fallen in the past 12 months: n (%) 80 (26.1) n = 307 86 (27.7) n = 310 166 (26.9) n = 617
Self-rated balance fair/poor: n (%) 99 (32.6) n = 304 96 (31.2) n = 308 195 (31.9) n = 612
Self-rated fear of falling ≥ moderate: n (%) 79 (25.7) n = 307 72 (23.4) n = 308 151 (24.6) n = 615
Total medications (n), mean (SD) 3.0 (2.6) n = 304 3.3 (2.7) n = 305 3.1 (2.7) n = 609
Medical conditions (0–17)a, mean (SD) 2.8 (1.9) n = 307 2.8 (2.0) n = 310 2.8 (1.9) n = 617
Arthritis: n (%) 173 (58.3) n = 297 181 (58.6) n = 309 354 (58.4) n = 606
Osteoporosis: n (%) 66 (21.7) n = 304 57 (18.6) n = 307 123 (20.1) n = 611
Diabetes: n (%) 26 (8.5) n = 306 32 (10.4) n = 307 58 (9.5) n = 613
Depression: n (%) 51 (16.8) n = 303 48 (15.8) n = 303 99 (16.3) n = 606
Self-report physical activity, hours/weekb: mean (SD) 33.4 (19.1) n = 306 34.3 (19.2) n = 309 33.9 (19.1) n = 615
SF12v2: physical composite score 48.0 (7.7) n = 304 47.8 (7.4) n = 298 47.9 (7.6) n = 602
SF12v2: mental composite score 53.4 (5.7) n = 304 53.6 (5.4) n = 298 53.5 (5.6) n = 602
Short FES-I, mean (SD) 9.7 (3.3) n = 307 9.4 (2.9) n = 309 9.6 (3.1) n = 616
Average daily step count, steps, mean (SD) 5725.9 (2424.6) n = 297 5539.6 (2394.5) n = 288 5634.2 (2409.5) n = 585
MVPA, minutes/day, mean (SD) 18.9 (17.4) n = 297 17.2 (16.8) n = 288 18.0 (17.1) n = 585
  1. Abbreviations: FES-I Falls Efficacy Scale-International, MVPA moderate vigorous physical activity
  2. aPossible medical conditions included: arthritis, osteoporosis, asthma, chronic obstructive pulmonary disease, angina, heart disease, heart attack, neurological disease, stroke/transient ischaemic attack, peripheral vascular disease, diabetes mellitus, upper gastrointestinal disease, depression, anxiety/panic disorder, visual impairment, hearing impairment, degenerative disc disease
  3. bMeasured using the Incidental and Planned Exercise Questionnaire (IPEQ)